Meningococcal B vaccine ineffective in gonorrhea prevention for men who have sex with men
medicalxpress - The meningococcal B vaccine is ineffective in gonorrhea prevention among men who have sex with men (MSM) at high risk of infection, according to findings from the world's largest randomized controlled trial (RCT) into possible efficacy published in the Ne…
AI Summary: A major study found that the meningococcal B (MenB) vaccine does not provide protection against gonorrhea in men who have sex with men, contradicting earlier hopes that cross-protection might exist. Researchers emphasize the need for dedicated gonorrhea vaccines and continued public-health measures to control rising infection rates.
Related Stories
Engineered 15‑strain biotherapeutic matches donor FMT for C. difficile / 5 wks
One hepatitis B drug shows early functional cures in trial / 6 wks
Deep learning discovers antibiotic leads against drug‑resistant gonorrhea / 21 days
Antiviral ensitrelvir dramatically cuts household COVID transmission risk / 1 month
UK begins human testing of first AI-designed 'universal' vaccine / 4 wks
Favipiravir shows promise in Lassa fever Phase 2 trial / 1 month
Dual Lassa–rabies vaccine phase 1 shows safety in humans / 4 wks
StackHealth RSS
You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Novo Nordisk, Genetics, Cybersecurity, Vaccine Safety and look for the RSS link.
StackHealth Time Machine